BioSpace News Archive

Aspargo Laboratories, Inc. (Aspargo), a privately held, clinical stage pharmaceutical company, today announced the results of its pre-Investigational New Drug (pre-IND) meeting with the United States Food & Drug Administration (FDA), where the FDA addressed Aspargo’s questions and provided guidance on the Company’s Sildenafil Oral Sp

Evelo Biosciences (Nasdaq:EVLO), a clinical stage biotechnology company developing a new modality of orally delivered, systemically acting biologics, today announced that it will host a conference call and live webcast at 8:30 a.m. ET on Monday, May 11, 2020 to report its first quarter 2020 financial results and discuss business highlights. To access the live conference call, please dial 866-795-3242 (domestic) or 409-937-8909 (international

EVERSANA™, the leading independent provider of global commercial services to the life sciences industry, today announced the appointment of Kelly Baker to Chief Financial Officer (CFO).

Brand New US-based pharmaceutical manufacturer, Tailstorm Health, Inc., DBA Medivant Healthcare, will begin to roll out sterile single dose liquid injectable medications on the FDA’s Drug Shortage List.

Aidoc announced that it obtained a European Union CE mark for the first AI solution for flagging incidental pulmonary embolism in contrast-enhanced CT.

Kryon®, the leading full-cycle automation solution provider known for its customer-centric approach to robotic process automation (RPA) and process discovery, today announces the frontline implementation of its Full-Cycle Automation solution in collaboration with the Information Systems and Digital Division at Clalit Health Services, the largest health service organization in Israel with 4.5 million members.

- ARS Pharmaceuticals’ lead product, ARS-1 (epinephrine nasal spray) to treat severe allergic reactions, has previously been granted Fast Track designation by the U.S. Food and Drug Administration (FDA) - Neurelis’ lead product, VALTOCO® (diazepam nasal spray), approved by the FDA for seizure cluster rescue, also utilizes Intravail® as a key component of its formulation - New data further highlight the permeation enhancement potency of Intravail® for both small and large mole

The Barbara Ann Karmanos Cancer Institute is pleased to announce that Eric A. Brown, M.D., FACS, breast surgeon, has joined its medical team, effective April 20, 2020.

Collaborative Action for SARS-CoV2-Eradication (CARE) is conducting a clinical trial to study the efficacy of a topical immune modulating drug Imiquimod cream with Hydroxychloroquine for primary and secondary prophylaxis of subjects with COVID19 infection.

Natera, Inc. (NASDAQ: NTRA), a pioneer and global leader in cell-free DNA testing, today announced the achievement of key recruitment milestones in the ProActive registry study and success in the Prospera early access program.